Efficacy Safety and Tolerability of DoravirineLamivudineTenofovir Disoproxil Fumarate FixedDose Combination Tablets in Adolescents Living With HIV Results Through Week 96 from IMPAACT 2014

Simple item page
dc.article.end-page609en
dc.article.start-page602en
dc.citation.doi10.1093/JPIDS/PIAD078en
dc.contributor.authorS Rungmaitreeen
dc.contributor.authorL Aurpibulen
dc.contributor.authorB Besten
dc.contributor.authorX Lien
dc.contributor.authorAvyi Violarien
dc.contributor.authorE et alen
dc.date.accessioned2024-07-23T06:00:29Z
dc.date.available2024-07-23T06:00:29Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn2048-7193en
dc.identifier.urihttps://hdl.handle.net/10539/39561
dc.journal.titleEfficacy Safety and Tolerability of DoravirineLamivudineTenofovir Disoproxil Fumarate FixedDose Combination Tablets in Adolescents Living With HIV Results Through Week 96 from IMPAACT 2014en
dc.journal.volume12en
dc.titleEfficacy Safety and Tolerability of DoravirineLamivudineTenofovir Disoproxil Fumarate FixedDose Combination Tablets in Adolescents Living With HIV Results Through Week 96 from IMPAACT 2014en
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
1.76 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download
Collections
Academic Wits Research Outputs (All submissions)